Abivax (ABVX) Cash & Current Investments (2021 - 2026)
Abivax (ABVX) recorded Cash & Current Investments of $457.33 million in Q2 2026, up 507.6% from $75.27 million a year earlier but down 19.1% from the prior quarter.
Powered by 
Analysis
Abivax (ABVX) Cash & Current Investments (2021 - 2026) Analysis & Trends
At the end of FY2025, Abivax reported Cash & Current Investments of $589.81 million, up 263.0% from FY2024.
- Annual Cash & Current Investments has a four-year compound annual growth rate of 68.4% (FY2021 to FY2025).
- Across earlier years, Cash & Current Investments came in at $162.5 million in FY2024 (-43.3%), $286.45 million in FY2023 (+603.1%), $40.74 million in FY2022 (-44.5%) and $73.42 million in FY2021.
- Quarterly Cash & Current Investments has ranged from $39.44 million in Q4 2022 to $695.36 million in Q3 2025 over the past five years.
- On a year-over-year basis, Cash & Current Investments has increased for four consecutive quarters, with growth averaging 179.2% over the last seven quarters.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 622.4% in Q4 2023, against a decline of 73.6% in Q2 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $565.26 million (Q1 2026), $607.68 million (Q4 2025) and $695.36 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Abivax | 7.09 Bn | 4.73 Bn | - | 469.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 469.09 Mn |
| Mar 31, 2026 | 553.31 Mn |
| Dec 31, 2025 | 632.12 Mn |
| Sep 30, 2025 | 702.57 Mn |
| Jun 30, 2025 | 80.88 Mn |
| Mar 31, 2025 | 120.28 Mn |
| Dec 31, 2024 | 157.94 Mn |
| Sep 30, 2024 | 201.56 Mn |
| Jun 30, 2024 | 251.76 Mn |
| Mar 31, 2024 | 260.80 Mn |
| Dec 31, 2023 | 289.02 Mn |
| Dec 31, 2022 | 28.73 Mn |
| Dec 31, 2021 | 68.74 Mn |
API Access
Abivax Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ABVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ABVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ABVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();